Our platform provides advanced market and disease analytics related to pharmaceuticals and medical devices by leveraging public data sources such as the 'National Patient Sample' and 'Healthcare claims' from the Health Insurance Review & Assessment Service, along with the 'Cohort' data from the National Health Insurance Service. This comprehensive analysis is delivered through a sophisticated big data platform optimized for claims analytics."